SUPERSONIC IMAGINE overview

Regulatory News: SuperSonic Imagine (Paris:ALSSI) (Euronext: SSI, FR0010526814, PEA-PME eligible) (the “ Company ”) which specializes in ultrasound medical imaging, informs its shareholders that the Company has decided to continue to refer to IFRS for the purposes of its financial communication for the year 2021 (contrary to what it had announced in its press release dated November 2, 2020 relating to the transfer of the listing of the Company's shares on the Euronext Growth Paris...

Regulatory News: SuperSonic Imagine (Paris:ALSSI) (Euronext Growth: ALSSI, FR0010526814, PEA-PME eligible, the “ Company ”), a company specializing in ultrasound medical imaging, today announces its sales for the first quarter 2021. In thousands of euros - unaudited 2021 2020 Change (%) Products 5,805 4,153 +40% % of total revenue 90% 85% Services 621 732 -15% % of total revenue 10% 15% 1 st quarter sales 6,426 4,885 32% Other revenue* - 26 Total Q1 revenue 6,426 4,911 31% *This revenue is...

Regulatory News: SuperSonic Imagine (Paris:ALSSI) (Euronext: ALSSI, FR0010526814, PEA-PME eligible), a company that specializes in ultrasound medical imaging (echography) (the “ Company ”), announces that its combined general shareholders’ meeting (both ordinary and extraordinary), has been held today at the Company’s registered office (the “ Shareholders’ Meeting ”). With the exception of the 5 th and 6 th resolutions (relating to related-party agreements submitted for its...

Regulatory News: On June 16, 2020, the annual general meeting of SuperSonic Imagine’s (Paris:ALSSI) (Euronext Growth: ALSSI, FR0010526814, PEA-PME eligible), a company that specializes in ultrasound medical imaging (echography) (the “ Company ”), having noted that, at the end of the fiscal year ended December 31, 2019, the amount of the Company’s shareholders’ equity had become less than half of the amount of its share capital, decided not to pronounce the early dissolution of the...

Regulatory News: SuperSonic Imagine (Paris:ALSSI) (Euronext Growth: ALSSI, FR0010526814, PEA-PME eligible, the “ Company ”), a company specializing in ultrasound medical imaging, today announces its annual results for the year to December 31, 2020, as approved by the Board on February 10, 2021. Antoine Bara, General Manager, says: “ 2020 was marked by the pandemic associated with Covid-19, the health crisis having impacted all the markets on which the Group operates. The company thus saw a...

Regulatory News: SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible) (Paris:SSI) which specializes in ultrasound medical imaging (the “ Company ”), informs that the transfer of the listing of the shares issued by the Company from the Euronext Paris regulated market (compartment C) to the Euronext Growth Paris multilateral trading facility (the “ Transfer ”), will be effective as from the trading session of December 30, 2020. In this respect, it is specified that the...

Regulatory News: SuperSonic Imagine (Paris:SSI): Hologic, Inc. (Nasdaq: HOLX) announced today 3D ultrasound imaging is now available on the SuperSonic™ MACH™ 40 ultrasound system*. Clinicians can now access high-resolution B-mode and ShearWave™ PLUS elastography 3D volumes, which are designed to enhance diagnostic certainty. With the 3D volumetric data acquired on the SuperSonic MACH 40 system, clinicians can see areas of interest from a new perspective. Breast tissue can be visualized in...

Regulatory News: SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible) (the “ Company ”) which specializes in ultrasound medical imaging , recalls that the Company’s Ordinary Shareholders’ Meeting held behind closed doors on October 30, 2020 approved the project to transfer the listing of securities issued by the Company from the Euronext Paris regulated market (compartment C) to the Euronext Growth Paris multilateral trading facility (the “ Transfer ”), and...